SCHEMBL31023784

SCHEMBL31023784

COc1ccc(N(c2ccc3c(c2)OCO3)C2CCN(C(=O)O)CC2)cc1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.48
L3MBTL1 Q9Y468 2/20 0.48
KMT2A Q03164 2/20 0.45
EDNRA P25101 2/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MAPK1 P28482 1/20 0.43
EDNRB P24530 1/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
MAPT P10636 2/20 0.43
DRD2 P14416 1/20 0.43
DRD3 P35462 1/20 0.43
TRPM8 Q7Z2W7 1/20 0.42
MCHR1 Q99705 2/20 0.42
BMP1 P13497 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31023799 0.87 BMP1 (0.54) SMN1; SMN2L3MBTL1KMT2AMEN1ALDH1A1
SCHEMBL31023754 0.85 ALDH1A1 (0.43) SMN1; SMN2L3MBTL1KMT2AMEN1ALDH1A1
SCHEMBL31023978 0.84 MGLL (0.47) SMN1; SMN2KMT2AMEN1ALDH1A1MAPK1
SCHEMBL31023843 0.79 ALDH1A1 (0.40) SMN1; SMN2L3MBTL1KMT2AEDNRAMEN1
SCHEMBL31023747 0.78 SCD5 (0.51) KMT2AMEN1MAPTBMP1
SCHEMBL31023855 0.76 MGLL (0.40) SMN1; SMN2L3MBTL1KMT2AMAPK1MAPT
SCHEMBL31023707 0.76 MGLL (0.40) SMN1; SMN2L3MBTL1KMT2AMAPK1MAPT
SCHEMBL31023933 0.75 MEN1 (0.55) KMT2AMEN1MAPTBMP1
SCHEMBL31023722 0.75 MGLL (0.49) KMT2AMEN1MAPTBMP1
SCHEMBL5197261 0.72 TRPM8 (0.48) SMN1; SMN2ALDH1A1MAPTTRPM8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4665718-A1 SMALL MOLECULES AS MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS, COMPOSITIONS AND USE THEREOF Apogee Pharmaceuticals, Inc. (CA) 2025-12-24 EP disclosed
WO-2024168426-A1 SMALL MOLECULES AS MONOACYLGLYCEROL LIPASE (MAGL) INHIBITORS, COMPOSITIONS AND USE THEREOF APOGEE PHARMACEUTICALS, INC. (CA) 2024-08-22 WO disclosed